Home > Boards > US Listed > Biotechs > Cel-Sci (CVM)

Anybody think we can print 45-50 tomorrow without data?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
learning curve Member Profile
 
Followed By 35
Posts 7,824
Boards Moderated 0
Alias Born 02/15/12
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 7/7/2021 3:25:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 10:51:52 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 10:49:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 10:45:24 AM
CEL-SCI says analysis of successful study arm was pre-specified in protocol Seeking Alpha - 7/7/2021 9:48:00 AM
CEL-SCI Corporation Issues Letter to Shareholders Business Wire - 7/7/2021 8:00:00 AM
CEL-SCI extends gains despite discussion on cancer trial Seeking Alpha - 7/2/2021 11:53:24 AM
Discussion of Results of CEL-SCI’s Phase 3 Trial Is Now Available Business Wire - 7/2/2021 11:20:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2021 6:01:17 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 9:13:04 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 9:06:14 AM
Ocuphire Pharma, Predictive Oncology leads healthcare gainers; Altimmune, electroCore among major losers Seeking Alpha - 6/30/2021 11:03:36 AM
CEL-SCI to further discuss late-stage Multikine data in head and neck cancer Seeking Alpha - 6/30/2021 10:59:10 AM
CEL-SCI to Conduct Investor Call Regarding Phase 3 Results Following Annual Shareholder Meeting on July 1, 2021 Business Wire - 6/30/2021 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 10:55:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/29/2021 8:30:14 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/28/2021 4:35:17 PM
CEL-SCI plummets 43% after phase 3 immunotherapy data misses primary endpoint Seeking Alpha - 6/28/2021 11:43:58 AM
CEL-SCI’s Multikine® Immunotherapy Produces Significant 14.1% 5-Year Survival Benefit (62.7% Vs 48.6%) in the Group Receiv... Business Wire - 6/28/2021 9:20:00 AM
CEL-SCI Corporation Invites Participants to Pre-Submit Questions for Annual Shareholder Meeting Business Wire - 6/25/2021 8:30:00 AM
CEL-SCI Announces the Closing of $31.7 Million Bought Deal Offering Business Wire - 6/11/2021 11:49:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/9/2021 4:09:46 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/9/2021 4:08:50 PM
CEL-SCI down 11% on $31.7M capital raise Seeking Alpha - 6/9/2021 3:56:17 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/9/2021 6:05:04 AM
learning curve   Friday, 05/14/21 12:40:49 AM
Re: None
Post # of 40256 
Anybody think we can print 45-50 tomorrow without data?
If i was a fund invited to the party a little late...Or didn’t take involvement in the reconciliation- yet....I would demand it!

Gert can swear all he wants publicly against so called shorts;
The truth is there are none non hedged and all attached directly to him...
So, for that little puppet to remain free he better do exactly what the master says!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences